Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mimetics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Mimetics

Mimetics

Mimetics: A tech and science company specializing in modeling biological processes.

HQ
Durham, NC, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded with a vision to revolutionize the understanding of biological processes, Mimetics specializes in modeling these processes through advanced computational and mathematical tools. The company aims to go beyond traditional 'omics' approaches by focusing on analyzing cell-level network dynamics. Their core mission is to provide deeper insights into cellular functions, which can be applied in various fields such as drug discovery, personalized medicine, and biotechnology.

Mimetics has garnered attention from notable scientists and investors in the biotech industry, contributing to its rapid growth and innovation. The company's achievements include developing cutting-edge models that have significantly advanced the understanding of cellular behavior. Through their pioneering work, Mimetics has made a substantial impact on both academic research and practical applications in healthcare, positioning itself as a key player in the field of computational biology.

Mimetics - Similar Companies

Metaphore Biotechnologies logo

Metaphore Biotechnologies

metaphorebio.com

Endomimetics logo

Endomimetics

endomimetics.com

BioDatomics logo

BioDatomics

biodatomics.com

Symic Biomedical logo

Symic Biomedical

Metalytics logo

Metalytics

Omix.ai logo

Omix.ai

Cellaria logo

Cellaria

cellariabio.com

MetaCell logo

MetaCell

metacell.us

Mitogenetics logo

Mitogenetics

mitogenetics.com

BioMimetix Pharmaceutical logo

BioMimetix Pharmaceutical

Selsym Biotech logo

Selsym Biotech

selsymbio.com

Via Scientific logo

Via Scientific

viascientific.com

Phenomix Sciences logo

Phenomix Sciences

MarvelBiome logo

MarvelBiome

marvelbiome.com

Vitra Bioscience logo

Vitra Bioscience

Mimetics - Quick Facts

Who are Mimetics' competitors?

Companies similar to Mimetics include Metaphore Biotechnologies, Endomimetics, BioDatomics and Symic Biomedical.

When was Mimetics founded?

Mimetics was founded in 2014.

Where is Mimetics' headquarters located?

Mimetics' headquarters is located in Durham, NC, US.

When was Mimetics' last funding round?

Mimetics' most recent funding round was for $74.6k (USD) in September 2022.

How much has Mimetics raised to-date?

As of Sep 22, 2022, Mimetics has raised a total of $299.5k (USD).

How many employees does Mimetics have?

Mimetics has 30 employees as of Feb 4, 2024.

Mimetics - Classification

Ownership
  • Private
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biological Modeling
Tags
  • Biotech
  • Data
  • Data Information
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software